Galmed Pharmaceuticals Ltd. buy Stifel Nicolaus
Start price
06.11.24
/
50%
€6.40
Target price
06.11.25
€85.67
Performance (%)
-
End price
07.11.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - | - |
| iShares Core DAX® | -1.764% | 2.259% | 15.213% |
| iShares Nasdaq 100 | -1.632% | -0.193% | 3.293% |
| iShares Nikkei 225® | -2.451% | 4.086% | 17.198% |
| iShares S&P 500 | -2.252% | -0.151% | 0.574% |
Comments by Stifel_Nicolaus for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Stifel Nicolaus from $80.00 to $92.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat
In the thread Trading Galmed Pharmaceuticals Ltd.
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten
Current prediction by Stifel_Nicolaus for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
21.02.25
21.02.25
€89.66
21.02.26
21.02.26
-
19.09.24
19.09.24
Stopped prediction by Stifel_Nicolaus for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.38
08.05.24
08.05.24
€65.08
08.05.25
08.05.25
1602.13%
09.05.25
09.05.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.34
21.02.24
21.02.24
€59.19
21.02.25
21.02.25
1782.35%
22.02.25
22.02.25